Natco Pharma plans to launch Molnupiravir capsules this week for treatment of COVID-19

Molnupiravir is the first COVID-19 drug authorised by the Drugs Controller General of India (DCGI) for the treatment of COVID-19 infection in adults who have high risk of progression of the disease including hospitalisation or death.